Skip to main content
. 2022 Jul 28;5:753. doi: 10.1038/s42003-022-03712-2

Fig. 4. Splenectomy abolished the therapeutic potential of ASCs.

Fig. 4

a Experimental scheme for analyzing the therapeutic potential of ASCs in rats treated with splenectomy. The rats underwent splenectomy 1 week before the nephrotoxic antibody injection. ASCs were administered on days 0, 2, and 4. b, c Serum creatinine level and histological crescent score on days 3 and 7 with and without splenectomy in each MSC treatment. d The tSNE plot shows the renal T-cell subset on day 3. e Frequency of renal leukocyte subsets in CD45+ cells analyzed by flow cytometry on days 3 and 7 (day 3, n = 4 per group; day 7, n = 7–8 per group). All data are shown as means ± SD. *p ≤ 0.05, ***p ≤ 0.001 as determined by Welch’s t test.